Epsilon Healthcare is rebadging its THC Pharma and Tetra Health divisions in a move to streamline operations under a single brand.

THC Pharma, which operates the company’s manufacturing facility in Southport, Queensland, will become Epsilon Pharma, while its telehealth clinic business will become Epsilon Clinics.

The company said alignment under the Epsilon Healthcare banner will provide the “launching platform” for new subsidiary verticals.  No further details on future verticals were disclosed.

The strategy will also enable the firm to create more focused marketing campaigns, Epsilon said.

Chief executive Peter Giannopoulos, who joined the company in late May, said: “With our new ‘one brand’ approach, we will be uniting the distinct subsidiary brands under the umbrella of Epsilon. Our future subsidiaries will follow this naming convention and it is hoped that in time our clients, both B2B and B2C, will benefit from the expanded Epsilon service verticals.”

Epsilon Healthcare was formerly known as THC Global before a rebrand in 2020.  

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...

Leave a comment